Skip to content

Clinical trials

Terminated Multiple Sclerosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Status: Terminated Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20102
20111
20121
20131
20141
20161
20175
20191
20202
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen5
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
Actelion1
Atara Biotherapeutics1
Celgene1
EMD Serono1
Elan Pharmaceuticals1
Health Sciences Centre, Winnipeg, Manitoba1
MedDay Pharmaceuticals SA1
Nimble Science Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis20
Multiple Sclerosis, Relapsing-Remitting4
Multiple Sclerosis, Chronic Progressive3
Autoimmune Diseases2
Demyelinating Diseases1
Epstein-Barr Virus Infections1
Fatigue1
Inflammation1
Neoplasm Metastasis1
Spinal Cord Injuries1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.